UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

1306 – The comparison of β-endorphin and cgrp levels in patients with severe symptoms of schizophrenia and in stable mental state after treatment

European psychiatry, 2013, Vol.28, p.1-1

2013

Volltextzugriff (PDF)

P-1322 - Objective evaluation of pain and β-endorphin, substance P, CGRP blood concentration in patients with schizophrenia

European psychiatry, 2012, Vol.27, p.1-1

2012

Volltextzugriff (PDF)

Oxidative stress in blood platelets from schizophrenic patients

Platelets (Edinburgh), 2005-11, Vol.16 (7), p.386-391

2005

Volltextzugriff (PDF)

P.1.c.019 The effect of lithium on oxidant–antioxidant balance in vitro and in neuronal cell cultures

European neuropsychopharmacology, 2011, Vol.21, p.S263-S264

2011

Volltextzugriff (PDF)

P.3.c.045 Glycine augmentation of antipsychotic treatment may improve depressive symptomatology in schizophrenic patients

European neuropsychopharmacology, 2012-10, Vol.22, p.S343-S343

2012

Volltextzugriff (PDF)

P.3.019 Impact of lithium on oxidative stress parameters in human plasma in vitro and neuroblastoma SH-SY5Y oxidative stress level and viability

European neuropsychopharmacology, 2012-03, Vol.22, p.S68-S68

2012

Volltextzugriff (PDF)

P.3.c.023 Glycine plasma levels are not a useful predictor of recovery in patients treated with glycine and neuroleptics

European neuropsychopharmacology, 2010, Vol.20, p.S470-S471

2010

Volltextzugriff (PDF)

P.1.b.001 Gender -related differences in white matter structure in early-onset schizophrenia subjects

European neuropsychopharmacology, 2011, Vol.21, p.S250-S250

2011

Volltextzugriff (PDF)

Diurnal profile of melatonin secretion in the acute phase of major depression and in remission

Medical science monitor, 2001-09, Vol.7 (5), p.946-952

2001

Volltextzugriff (PDF)

Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms

Journal of psychiatric research, 2001-07, Vol.35 (4), p.249-257

2001

Volltextzugriff (PDF)

P.1.e.002 Diffusion tensor imaging findings in early-onset schizophrenia patients

European neuropsychopharmacology, 2010, Vol.20, p.S288-S289

2010

Volltextzugriff (PDF)

P.3.a.018 Changes in antisaccadic test, gain and negative symptoms in schizophrenic patients treated with glycine

European neuropsychopharmacology, 2008, Vol.18, p.S395-S396

2008

Volltextzugriff (PDF)

P.3.d.022 The effects of quetiapine, olanzapine and haloperidol on human plasma lipid peroxidation in vitro

European neuropsychopharmacology, 2009, Vol.19, p.S566-S567

2009

Volltextzugriff (PDF)

The links between body dysmorphic disorder and eating disorders

European psychiatry, 2000-08, Vol.15 (5), p.302-305

2000

Volltextzugriff (PDF)

P.3.c.017 Polish patients of the EUFEST study after 1 year antipsychotic treatment: drug discontinuation and metabolic syndrome parameters

European neuropsychopharmacology, 2010, Vol.20, p.S467-S467

2010

Volltextzugriff (PDF)

P.3.d.023 The effects of quetiapine and haloperidol on human plasma lipid peroxidation in vitro

European neuropsychopharmacology, 2008, Vol.18, p.S461-S462

2008

Volltextzugriff (PDF)

P.3.15 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients

European neuropsychopharmacology, 2008, Vol.18, p.s74-s75

2008

Volltextzugriff (PDF)

"Breakwater"- The preventive and therapeutic programme for the first degree relatives of schizophrenic patients

European psychiatry, 2008-04, Vol.23, p.S125-S125

2008

Volltextzugriff (PDF)

P.3.a.013 Decreased bone mineral density in patients with schizophrenia treated with risperidone or olanzapine

European neuropsychopharmacology, 2007, Vol.17, p.S408-S409

2007

Volltextzugriff (PDF)

P.3.d.018 The effects of the antipsychotic drugs on collagen-induced platelet aggregation in vitro

European neuropsychopharmacology, 2007, Vol.17, p.S483-S484

2007

Volltextzugriff (PDF)

P.3.a.015 Relation between working memory and negative symptoms and other factors in patients with first episode of schizophrenia

European neuropsychopharmacology, 2007, Vol.17, p.S409-S410

2007

Volltextzugriff (PDF)

Hyperprolactinaemia in patients with schizophrenia treated with risperidone or olanzapine, correlations with age of patients and lengh of treatment

European psychiatry, 2007-03, Vol.22, p.S144-S145

2007

Volltextzugriff (PDF)

P.3.d.017 The atypical and classical antypsychotic drugs affect adenosine diphosphate-induced platelet aggregation

European neuropsychopharmacology, 2007, Vol.17, p.S483-S483

2007

Volltextzugriff (PDF)

peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may induce working memory disturbances in chronic hepatitis c (CHC) patients

European psychiatry, 2007-03, Vol.22, p.S303-S303

2007

Volltextzugriff (PDF)

Attention abnormalities in chronic hepatitis c (CHC) patients during peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may persist after treatment discontinuation

European psychiatry, 2007-03, Vol.22, p.S303-S304

2007

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(68)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(36)
Psychiatry
(32)
Female
(28)
Internal Medicine
(24)
Male
(22)
Adolescent
(20)
Adult
(18)
Psychiatric Status Rating Scales
(16)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Child
(9)
Schizophrenia
(6)
Adult And Adolescent Clinical Studies
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Psychology. Psychoanalysis. Psychiatry
(5)
Psychopathology. Psychiatry
(5)
Retrospective Studies
(5)
Somatoform Disorders - Psychology
(5)
Child, Preschool
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1306 – The comparison of β-endorphin and cgrp levels in patients with severe symptoms of schizophrenia and in stable mental state after treatment

P-1322 - Objective evaluation of pain and β-endorphin, substance P, CGRP blood concentration in patients with schizophrenia

Oxidative stress in blood platelets from schizophrenic patients

P.1.c.019 The effect of lithium on oxidant–antioxidant balance in vitro and in neuronal cell cultures

P.3.c.045 Glycine augmentation of antipsychotic treatment may improve depressive symptomatology in schizophrenic patients

P.3.019 Impact of lithium on oxidative stress parameters in human plasma in vitro and neuroblastoma SH-SY5Y oxidative stress level and viability

P.3.c.023 Glycine plasma levels are not a useful predictor of recovery in patients treated with glycine and neuroleptics

P.1.b.001 Gender -related differences in white matter structure in early-onset schizophrenia subjects

Diurnal profile of melatonin secretion in the acute phase of major depression and in remission

Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms

P.1.e.002 Diffusion tensor imaging findings in early-onset schizophrenia patients

P.3.a.018 Changes in antisaccadic test, gain and negative symptoms in schizophrenic patients treated with glycine

P.3.d.022 The effects of quetiapine, olanzapine and haloperidol on human plasma lipid peroxidation in vitro

The links between body dysmorphic disorder and eating disorders

P.3.c.017 Polish patients of the EUFEST study after 1 year antipsychotic treatment: drug discontinuation and metabolic syndrome parameters

P.3.d.023 The effects of quetiapine and haloperidol on human plasma lipid peroxidation in vitro

P.3.15 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients

"Breakwater"- The preventive and therapeutic programme for the first degree relatives of schizophrenic patients

P.3.a.013 Decreased bone mineral density in patients with schizophrenia treated with risperidone or olanzapine

P.3.d.018 The effects of the antipsychotic drugs on collagen-induced platelet aggregation in vitro

P.3.a.015 Relation between working memory and negative symptoms and other factors in patients with first episode of schizophrenia

Hyperprolactinaemia in patients with schizophrenia treated with risperidone or olanzapine, correlations with age of patients and lengh of treatment

P.3.d.017 The atypical and classical antypsychotic drugs affect adenosine diphosphate-induced platelet aggregation

peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may induce working memory disturbances in chronic hepatitis c (CHC) patients

Attention abnormalities in chronic hepatitis c (CHC) patients during peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may persist after treatment discontinuation

Suchergebnisse filtern